EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation
IntroductionColorectal cancer and other adult solid cancers pose a significant challenge for successful treatment because the tumor microenvironment both hinders the action of conventional therapeutics and suppresses the immune activities of infiltrating leukocytes. The immune suppression is largely...
Main Authors: | Haein Huh, Ding-Wen Chen, Marianna Foldvari, Roderick Slavcev, Jonathan Blay |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.957233/full |
Similar Items
-
Biological foundations of successful bacteriophage therapy
by: Carola Venturini, et al.
Published: (2022-07-01) -
Efficacy of Individual Bacteriophages Does Not Predict Efficacy of Bacteriophage Cocktails for Control of Escherichia coli O157
by: Yan D. Niu, et al.
Published: (2021-02-01) -
Isolation and Characterization of the Novel Bacteriophage AXL3 against <i>Stenotrophomonas maltophilia</i>
by: Jaclyn G. McCutcheon, et al.
Published: (2020-09-01) -
Application of Bacteriophages in Nanotechnology
by: Jan Paczesny, et al.
Published: (2020-09-01) -
Advance on Engineering of Bacteriophages by Synthetic Biology
by: Sun Q, et al.
Published: (2023-03-01)